Post-transplant lymphoproliferative disorders following solid-organ transplantation.
about
Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cellsThe accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.Polyclonal gammopathy related to renal bleeding in a peritoneal dialysis patient.The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.Risk factors for post-transplant lymphoproliferative disease in patients with cystic fibrosis.Primary pulmonary lymphoproliferative neoplasms.
P2860
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@en
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@nl
type
label
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@en
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@nl
prefLabel
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@en
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@nl
P2860
P356
P1476
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
@en
P2093
Anne H Blaes
Vicki A Morrison
P2860
P356
10.1586/EHM.09.76
P577
2010-02-01T00:00:00Z